The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19

NCT04805086 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Fibrosis
Interstitial Lung Disease
Covid19

Interventions

BIOLOGICAL: MON002

Sponsor

Guy's and St Thomas' NHS Foundation Trust

Collaborators

[object Object]